Given that obesity and hypertension frequently coexist and together substantially increase cardiovascular and kidney risk, these findings support obesity treatment as an important component of blood pressure management and cardiovascular risk reduction, said lead researcher Marcel Muskiet, MD, PhD, an internist, endocrinologist, and vascular medicine specialist in the Department of Medicine at Leiden University Medical Center (LUMC) in the Netherlands
Medical Weight Loss at Klinic Klinic in Coldwater, Michigan provides a tailored medical weight loss program that connects you with FDA-approved weight loss medications
As the study found that GLP-1 medications are more likely to provide heart health protection over time, stopping treatment earlier means they are less likely to offer these benefits
These reports come from health forums, prescription review websites, and post-marketing safety data
Cagrilintide is an amylin receptor agonist that works through yet another pathway
